Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of an all-D-pentapeptide chemokine antagonist to reduce opioid dose in a person with pain

Use of an all-D-pentapeptide chemokine antagonist to reduce opioid dose in a person with pain

US Patent RE50630 · Granted Oct 14, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of an all-D-pentapeptide chemokine antagonist to reduce opioid dose in a per2025
Methods and compositions for use of a chemokine receptor antagonist peptide to t2025
Methods and compositions for use of a chemokine receptor antagonist peptide to t2022
Therapeutic peptides and vaccines2021
Anti-inflammatory peptides for treating non-alcoholic steatohepatitis (NASH)2020
Use of an all-D-pentapeptide chemokine antagonist to reduce opioid dose in a per2020
Uses of peptides to treat brain injury and disease2019
Modified peptide that reduces pain in peripheral neuropathy2018
Therapeutic peptides and vaccines2018
Method of treating HIV in drug resistant non plasma viral reservoirs with monome2012
Therapeutic peptides and vaccines2010
Peptide pharmaceutical compositions2008